8 Followers on Owler
Kanyos develops and provides immune tolerance therapies for autoimmune diseases such as type-1 diabetes and celiac disease... Read more
OverviewCompetitorsFundingNews & Insights
Kanyos develops and provides immune tolerance therapies for autoimmune diseases such as type-1 diabetes and celiac disease... Read more
Kanyos Bio President & CEO: John A Hohneker

President & CEO

John A Hohneker

CEO Approval Rating

85/100

2014

PrivateSubsidiary of Anokion SA

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$16M

News

Sep 11, 2019
FinSMEs
Kanyos Bio: Anokion Raises $40M; Acquires Kanyos Bio
Jan 18, 2018
Business Wire
Kanyos Bio: Anokion Announces Appointment of Dr. John Hohneker as Chief Executive Officer
Mar 16, 2016
4-traders
Kanyos Bio: Astellas Pharma : Kanyos Bio Raises USD16 Million in Venture Financing

Kanyos Bio Competitors

1Kineta
2Serimmune
3Cyteir
4Toleranzia AB
5Protagen
6SuppreMol
7NexImmune
8Paragen Bio
9Baxalta
10PharmAkea
Unlock 13 + competitors

Trending Companies